Introduction
After the US Food and Drug Administration (FDA) approval of laser in situ keratomileusis (LASIK), early laser platform users began reporting incidents of keratectasia. 1, 2 It was unclear whether these preliminary instances of ectasia were isolated consequences of a newly developed technology or the first of many cases to come. 3 In the following years, the high volume of LASIK procedures performed revealed ectasia to be a persistent, albeit rare, postoperative complication. Detection of ectasia became easier as prognostic markers, such as the Randleman Ectasia Risk Score System (ERSS) and percent tissue altered (PTA), accrued in the literature and surgical predictability increased. To date, the prevalence of ectasia after LASIK has been estimated to be quite low, between 0.04% and 0.6%. 4 Nevertheless, the sensitivity of current risk submit your manuscript | www.dovepress.com
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Moshirfar et al assessment modalities remains disputed due to the highly multifactorial nature of ectasia. 5, 6 Small-incision lenticule extraction (SMILE) is an alternative to LASIK that has demonstrated less dry eye symptoms, a lack of flap-related complications, and less injury to the subbasal nerve plexus. [7] [8] [9] [10] [11] [12] With the exception of a small side cut incision through which the refractive lenticule is extracted, SMILE preserves the collagen networks of the anterior stroma that account for ~60% of the total corneal tensile strength. 13, 14 Even though SMILE is thought to reduce the probability of iatrogenic ectasia compared to LASIK, only four cases have been reported in the literature. 15 In this review, we provide a concise summary of these cases and reiterate the importance of a conservative approach to performing SMILE on patients with suspicious topographies.
Methods
A literature review was performed using the following electronic databases: PubMed, Scopus, Ovid Medline, Embase, ScienceDirect, Google Scholar, and Cochrane Library. Publications were drawn between the dates of 2011 and July 2017. Key words used in the search queries included "ectasia" or "keratoconus" and "small incision lenticule extraction" or "SMILE" or "ReLEx SMILE". There were no language restrictions.
We reviewed patient characteristics information including age, sex, manifest refraction, cylinder, and spherical equivalent. Preoperative information such as topography, central corneal thickness (CCT), and anterior keratometry (Km) was also noted. The preoperative risk of ectasia in reported cases was measured using the Randleman ERSS.
Two of the case reports did not include parameter data such as cap diameter, cap thickness (CT), optical zone, and maximum lenticule thickness (LT). 16, 17 In addition, three of the four patients did not have residual stromal bed (RSB) values reported. For these specific eyes, maximum LT and PTA were calculated using VisuMax ReLEx SMILE software Version 2.10.10 (Carl Zeiss Meditec AG, Jena, Germany), assuming the conventional parameters for a cap diameter of 7.10 mm, CT of 120 μm, and optical zone of 6.50 mm. RSB values were then calculated using CT and maximum LT subtracted from CCT.
Compliance with ethics guidelines
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1964 Declaration of Helsinki, as revised in 2013.
Results
Seven eyes of four patients who underwent bilateral SMILE for myopia and myopic astigmatism correction were noted to develop ectasia. [16] [17] [18] [19] The mean refractive error was −3.56±2.11 (range: −1.5 to −6.75 D) with a mean cylinder of −1.12±0.38 (range: −0.5 to −1.25). The mean manifest refraction spherical equivalent (MRSE) was −4.13±2.08 (range: −2.25 to −7.25). Preoperative patient characteristics and lenticule parameters are listed in Tables 1 and 2 , respectively.
Cases of post-SMILE ectasia were reported in China, Egypt, Finland, and India. All patients were male with an average age of 26±5 years (range: 19-33 years). None of the patients studied reported a family history of keratoconus. The mean preoperative CCT was 520±29 μm (range: 513-559 μm). All patients had preoperative corrected distance visual acuity (CDVA) of 20/20 or better. The mean reported preoperative anterior Km was 42.28±1.6 (range: 40.4-45.1). The mean calculated RSB was 321±35 (range: 288-389). The mean Randleman Ectasia Risk Score was 4±3 (range: 1-8) with five eyes categorized as being at high risk and three eyes being identified as low risk for ectasia after LASIK. The mean calculated PTA was 38%±6% (range: 30%-47%) with six eyes having a PTA ,40% and two eyes having a PTA .40%. Based on proposed PTA safety thresholds, two eyes were recognized to be at high risk for ectasia.
Two patients were diagnosed with subclinical keratoconus in both eyes. One patient was diagnosed with unilateral mild keratoconus (OD) preoperatively and normal topography in the other eye (OS) that progressed to bilateral ectasia. 16 The fourth patient had normal topography in both eyes preoperatively, which later progressed to unilateral ectasia (OS). 19 Overall, five eyes of the four patients displayed abnormal preoperative topographies but underwent SMILE nevertheless. The diagnosis of postoperative ectasia in these patients was made in an average of 6.4 months (range: 1-12 months) after surgery.
Discussion
SMILE is believed to have less of a biomechanical impact on the integrity of the cornea than LASIK. 20, 21 Tissue removal in SMILE occurs much deeper than in LASIK, avoiding the interruption of the strong interweaving, steeper angles, and sheer stress of the anterior stroma. 22 Specifically, SMILE is thought to result in greater stromal collagen stiffness and less deformations in the RSB when compared to LASIK. 23 Although the theoretical risk of ectasia may be reduced, it is not completely eliminated due to the disruption of stroma that 24 In the four cases described, preoperative abnormal topography was noted in three patients with post-SMILE ectasia. Ectasia occurred soon after surgery in these patients. This suggests that SMILE may not be suitable for patients exhibiting subclinical keratoconus, similar to LASIK. One case reported ectasia with normal preoperative topography, signifying that abnormal topography may not be the only risk factor for developing ectasia after SMILE.
An RSB of ,300 μm is thought to be a risk factor for ectasia after LASIK. 25 Although this principle has been applied to SMILE, practitioners currently do not know what the safety threshold for RSB should be. It has been hypothesized that leaving a thinner RSB may be a viable parameter for achieving higher myopic correction in SMILE. Practitioners who recognize the improved biomechanics of SMILE have proposed extracting a deeper lenticule and leaving a lower safety threshold RSB given the preserved integrity of the stronger anterior stroma. 26 For example, an RSB of 220 μm may be attainable with conservative estimations using a CT of 120 μm, comprising a corneal epithelium of 40 μm and an anterior stroma of 80 μm. This would result in a theoretically unaltered stromal tissue of 380 μm, if the tensile strength of 80 μm of anterior stroma is considered equivalent to that of 160 μm of posterior stroma. 27 However, this hypothesis may not hold true given that patients in this review developed ectasia despite having an RSB of .300 μm. Table 2 shows that five eyes had the safety threshold RSB within ±10 μm.
The Randleman ERSS for LASIK incorporates a number of ectasia risk factors that may be relevant to SMILE. For example, the ERSS evaluates CCT, age, myopia, RSB, and topography to measure a patient's postoperative risk. [28] [29] [30] Based on the data in Table 1 , five out of eight ectatic eyes (62.5%) in this review would have been identified as high risk by this system based on abnormal topography alone. Screening with this system would have likely precluded three patients from undergoing LASIK. Thus, the Randleman system may also have a practical use in the routine evaluation of patients before SMILE. Utilizing a calculated PTA, only two out of eight eyes (25%) were classified as high risk. In these patients, the Randleman system was a more sensitive screening metric. Santhiago et al [31] [32] [33] had previously reported that a PTA .40% was more predictive of ectasia risk than moderate-to-high ERSS values for LASIK patients. Based on the cases reviewed, PTA alone may not be sensitive or specific enough for ectasia risk after SMILE. However, it should be noted that Santhiago et al applied this .40% cutoff to patients presenting with normal topography. In patients with abnormal topography, such as those in this study, they suggested that 
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Moshirfar et al the safety threshold for PTA in SMILE may be lower than that in LASIK, but no specific cutoff was endorsed. 34 Currently, Santhiago 35 has put forth a revised evaluation of PTA, specific for SMILE, which examines the relationship of the LT, CT, and CCT such that PTA = (CT + LT)/CCT. From a conceptual basis, the amount of tissue altered in SMILE is less compared to that in LASIK. We believe that this notion necessitates the use of a correction factor to the original formula put forth by Santhiago et al. Vertical side cuts through the corneal lamellae are thought to weaken corneal structural integrity more than horizontal delamination incisions during LASIK flap creation. 36 If this concept holds true for SMILE, the ratio of vertical incision between these two procedures can be determined. We began by computing the ratio of incision length to total circumference for each procedure as illustrated in Figure 1 . For a LASIK flap diameter of 8.75 mm, a hinge angle of 55°, and a flap circumference of 27.5 mm, the actual LASIK flap incision length would be 23.3 mm. Assuming a SMILE cap diameter of 7.5 mm, smallincision angle of 90°, and cap circumference of 23.6 mm, the small-incision length would be equal to 5.89 mm. The resulting ratio of small-incision length to total SMILE cap circumference (S) would be 0.25. Similarly, the ratio of LASIK flap incision length to total flap circumference (L) would be 0.85. Therefore, the ratio of S/L would be equal to 0.30. This ratio can be interpreted theoretically as SMILE inducing 70% less disruption of anterior corneal lamellae than LASIK for an identical myopic correction.
We offer a modified PTA (mPTA) formula that accounts for this difference in anterior corneal lamellae disruption between the two procedures using the ratio discussed earlier. This mPTA should be calculated using the formula, mPTA = [(S/L) × CT + LT]/CCT, and the mean mPTA was found as 22%±6% (range: 15%-32%). Although no safety threshold PTA value for SMILE has been endorsed, we believe that an mPTA value of approximately 20% may be considered as high risk. If we apply this threshold to the patients in this study, five out of eight eyes (62.5%) would have been identified as high risk. This threshold could be used to assess patient ectasia risk for SMILE and may even be lower in patients with abnormal topography. Still, we cannot say for certain that our modified formula will result in a PTA for SMILE that is sensitive or specific. More specific biomechanical data from post-SMILE ectasia cases are needed to fully delineate the association between PTA and the risk for postoperative ectasia.
Conclusion
We have reviewed four cases of postoperative ectasia following SMILE. Ectasia was found to be more common in patients with underlying corneal pathology but was also seen in a patient with normal topography. Thus, ectasia may be a risk inherently associated with the SMILE procedure. If implemented, the Randleman's criteria would have precluded three patients from undergoing SMILE, whereas PTA alone would have only identified one patient as high risk for ectasia. We propose that SMILE may cause 70% less disruption of the anterior corneal lamellae when compared to LASIK and offer a modified formula for PTA in SMILE. A low threshold for mPTA, approximately 20%, could indicate a high risk for ectasia after SMILE. However, determination of an accurate calculation of PTA must be developed using data from patients who had ectasia after SMILE in the absence of risk factors.
There have been .750,000 cases of SMILE performed worldwide, and only four cases of ectasia have been reported. We currently lack the sufficient long-term follow-up evidence needed to thoroughly assess ectasia risk, but we assume that the risk will be similar to, if not less than, post-LASIK ectasia. Further studies should examine the patient characteristics that predispose individuals to develop ectasia after SMILE in the absence of risk factors and compare those to similar patients who developed ectasia following LASIK. Additionally, a thorough review of the screening protocols currently used before SMILE may illuminate areas for improvement using corneal biomechanical and wavefront principles. Until specific risk screening metrics for SMILE have been validated, caution should be exercised in patients with abnormal topography. For now, we recommend the same contraindication criteria for LASIK be adopted to the SMILE procedure.
Data availability
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